Related Experiment Video

Updated: Mar 11, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K

Down-regulation of salt-inducible kinase 1 (SIK1) is mediated by RNF2 in hepatocarcinogenesis

Chao Qu1, Yaqin Qu1

  • 1Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.

Oncotarget
|December 3, 2016
PubMed

Insights

RNF2 targets SIK1 for degradation in hepatocellular carcinoma (HCC). Inhibiting RNF2 or restoring SIK1 levels may offer a new therapeutic strategy for HCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Previous research indicated that reduced Salt-inducible kinase 1 (SIK1) expression promotes hepatocellular carcinoma (HCC) growth and invasion.
  • The precise mechanisms driving SIK1 down-regulation in HCC remain largely unelucidated.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying SIK1 down-regulation in HCC.
  • To identify upstream regulators of SIK1 and assess their therapeutic potential in HCC.

Main Methods:

  • Correlation analysis of RNF2 and SIK1 expression in HCC tissues.
  • Kaplan-Meier survival analysis.
  • In vitro and in vivo experiments involving RNF2 and SIK1 manipulation in HCC cells and xenograft models.
  • Ubiquitination assays and co-immunoprecipitation to determine the interaction between RNF2 and SIK1.

Main Results:

  • RNF2 expression was inversely correlated with SIK1 levels in HCC tissues.
  • High RNF2 and low SIK1 expression predicted poor patient survival.
  • RNF2 depletion reduced HCC cell growth and metastasis.
  • RNF2 functions as an E3 ligase targeting SIK1 for proteasomal degradation via direct physical interaction.
  • Simultaneous knockdown of RNF2 and SIK1 rescued the anti-tumor effects observed with RNF2 depletion alone.

Conclusions:

  • RNF2 acts as a key upstream negative regulator of SIK1 in HCC by promoting its degradation.
  • Loss of RNF2 leads to SIK1 restoration, inhibiting HCC cell proliferation and metastasis, and promoting apoptosis.
  • Targeting the RNF2-SIK1 axis presents a potential therapeutic strategy for hepatocellular carcinoma.
Keywords:
RNF2SIK1liver cancerubiquitination

More Related Videos

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

596
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

8.1K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Transcriptional Regulation: Riboswitches01:23

Transcriptional Regulation: Riboswitches

Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
979